Results 161 to 170 of about 15,525 (208)

Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition. [PDF]

J Immunother Cancer
Lee SN, Arseneau RJ, Arnason T, Boudreau JE.   +3 more
europepmc   +1 more source

Regulation des humanen NKG2A Promotors

, 2005
openaire   +1 more source

Ocena komórek CD94/NKG2A w chłoniakach nieziarniczych (n-HL)

Acta Haematologica Polonica, 2007
Kiełbiński, Marek, Kapelko-Słowik, Katarzyna, Kuliczkowski, Kazimierz   +2 more
openaire  

Immune cells in keloids: mechanisms and potential treatments. [PDF]

Ann Med
Wu Y, Huang Y, Zhang H, Dong C, Chen X.
europepmc   +1 more source

Genetic Variability in NKG2 Receptors and Their Ligands: Associations with SARS-CoV-2 Infection and COVID-19 Severity. [PDF]

Genes (Basel)
Siemaszko J, Grad K, Świerkot J, Bogunia-Kubik K.   +3 more
europepmc   +1 more source

CD127⁺ Natural Killer Cells Represent a Distinct, Interleukin-15-Independent and Thymus-Independent Subset in Mice. [PDF]

Int J Mol Sci
Kim Y, Hwang SY, Kwon YJ, Kim JE, Rajbongshi L, Lee SR, Joo S, Park S, Oh SO, Kim BS, Lee D, Yoon S.   +11 more
europepmc   +1 more source

Natural killer cell dysfunction in glioma: from immune evasion to immunotherapy. [PDF]

Front Immunol
Zhang R, Ma P, Tang K, Cao Y, Yang Y, Hao S, Li T, Peng X.   +7 more
europepmc   +1 more source

PD-1⁺ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade. [PDF]

J Exp Clin Cancer Res
Greppi M, Tabellini G, Patrizi O, Obino V, Bozzo M, Rutigliani M, Gorlero F, Di Luca M, Paleari L, Melaiu O, Paudice M, Loiacono F, Castagnola P, Vellone VG, André P, Mavilio D, Ubezio G, Candiani S, Jandus C, Moretta L, De Censi A, Olive D, Sivori S, Vivier E, Rampinelli F, Parolini S, Pesce S, Marcenaro E.   +27 more
europepmc   +1 more source

Therapeutic Intensification Based on Immune Checkpoint Inhibitors in Non-Muscle Invasive Bladder Cancer: State of the Art and Future Perspectives. [PDF]

Cancers (Basel)
Gabriel PE, Horowitz A, Guerrero-Ramos F, Soria F, Moschini M, D'Andrea D, Pradère B, Sfakianos JP, Xylinas E.   +8 more
europepmc   +1 more source

Bystander CD8⁺ conventional memory versus virtual memory T cells in the initial days post-<i>Trypanosoma cruzi</i> infection. [PDF]

Front Immunol
Viano ME, Baigorri RE, Bergero G, Aoki MP, Lidon NL, Teixeira MG, Herrera MR, Motran CC, Cerban FM, Stempin CC, Rodriguez-Galan MC.   +10 more
europepmc   +1 more source